Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study of Intravenous Staphylococcal Protein A in Patients with Active Rheumatoid Arthritis On Methotrexate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2015
Price :
$35
*
At a glance
- Drugs Staphylococcal-protein-A (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Protalex
- 16 Apr 2015 Following an exploratory biomarker analysis of data from the PRTX100-104 study, Protalex intends to re-examine biomarkers from this trial and perform combined analysis of the 103 Study and 104 Study biomarkers, according to a media release.
- 15 Aug 2013 Results will be published in the Journal of Clinical Pharmacology according to a Protalex media release.
- 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.